Serotonergic and Adrenergic Drug Interactions Associated with Linezolid: A Critical Review and Practical Management Approach

Abstract

Spanish

French

OBJECTIVE

To describe the evidence for serotonergic and adrenergic drug interactions with linezolid and discuss clinical management strategies.

DATA SOURCES

A literature search of PubMed (1947–November 2012), MEDLINE (1946–November 2012), EMBASE (1974–November 2012), and International Pharmaceutical Abstracts (1970–November 2012) was conducted using the terms linezolid, drug interaction, serotonin syndrome, serotonin toxicity, sympathomimetic, serotonergic agents, and adrenergic agents. Citations of retrieved articles were also reviewed.

STUDY SELECTION AND DATA EXTRACTION

English-language articles describing coadministration of serotonergic or adrenergic agents with linezolid to humans were included. Studies published only in abstract form were excluded.

DATA SYNTHESIS

One prospective study, 6 retrospective studies, and 24 case reports were identified describing a serotonergic or adrenergic drug interaction. Incidence of serotonin syndrome in patients on linezolid and serotonergic agents ranged between 0.24% and 4%. Serotonergic agents determined to have probable (according to the Horn Drug Interaction Probability Scale) linezolid interactions in case reports included meperidine, citalopram, escitalopram, fluoxetine, paroxetine, sertraline, duloxetine, and venlafaxine. Serotonergic agent dose and duration of coadministration with linezolid did not appear to influence the occurrence of serotonin syndrome. Adrenergic medication coadministration was associated with a possible drug interaction as determined by the Horn Drug Interaction Probability Scale but did not appear to result in clinically significant drug interactions with linezolid.

CONCLUSIONS

Linezolid-associated serotonergic drug interactions occur more commonly than adrenergic interactions. Serotonergic interactions considered probable according to the Horn Drug Interaction Probability Scale do not appear to correlate with drug dosage; time of onset ranges from <1 to 20 days, and effect resolves in <1 to 5 days after discontinuation of offending agents. If coadministration of linezolid and a serotonergic agent cannot be avoided, clinicians should be aware of the symptoms and management of serotonergic toxicity; close monitoring is recommended and additional serotonergic agents should not be used. While adrenergic drug interactions with linezolid are less common in clinical practice, monitoring for signs of hypertension remains important.

Get full access to this article

View all access options for this article.

References

1. Product monograph. Zyvoxam (linezolid). Kirkland, Quebec: Pfizer Canada Inc., Oct 5, 2009. www.pfizer.ca/en/our_products/products/monograph/143 (accessed 2012 Sept 18).

2. MacDougall

, Chambers

. Protein synthesis inhibitors and miscellaneous antibacterial agents. In: Brunton

, Chabner

, Knollmann

, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill, 2011. www.accessmedicine.com/content.aspx?aID=16677888 (accessed 2012 Sept 18).

3. Stalker

, Jungbluth

. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial. Clin Pharmacokinet 2003; 42: 1129–40.

4. Boyer

, Shannon

. The serotonin syndrome. N Engl J Med 2005; 352: 1112–20.

5. Gillman

. A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action. Biol Psychiatry 2006; 59: 1046–51.

6. Flomenbaum

, Goldfrank

, Hoffman

, Howland

, Lewin

, Nelson

. Initial evaluation of the patient: vital signs and toxic syndromes. In: Goldfrank's toxicologic emergencies. 8th ed. New York: McGraw-Hill Medical, 2006: 231–2.

7. Sternbach

. The serotonin syndrome. Am J Psychiatry 1991; 148: 705–13.

8. Dunkley

, Isbister

, Sibbritt

, Dawson

, Whyte

. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96: 635–42.

9. Baxter

, ed. Stockley's drug interactions [online]. London: Pharmaceutical Press, 2012. www.medicinescomplete.com.ezproxy.library.ubc.ca/ (accessed 2012 Sept 18).

10.

10. Horn

, Hansten

, Chan

L-N

. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 2007; 41: 674–80. DOI: 10.1345/aph.1H423

11.

11. Hines

, Malone

, Murphy

. Recommendations for generating, evaluating, and implementing drug-drug interaction evidence. Pharmacotherapy 2012; 32: 304–13.

12.

12. Hendershot

, Antal

, Welshman

, Batts

, Hopkins

. Linezolid: pharmacokinetic and pharmacodynamic evaluation of coadministration with pseudoephedrine HCl, phenylpropanolamine HCl, and dextromethorpan HBr. J Clin Pharmacol 2001; 41: 563–72.

13.

13. Butterfield

, Lawrence

, Reisman

, Huang

, Thompson

, Lodise

. Comparison of serotonin toxicity with concomitant use of either linezolid or comparadors and serotonergic agents: an analysis of Phase III and IV randomized clinical trial data. J Antimicrob Chemother 2012; 67: 494–502.

14.

14. Bishop

, Melvani

, Howden

, Charles

, Grayson

. Good clinical oetcomes but high rates of adverse reactions during linezolid thebapy for serious infections: a pboposed protocol for monitoring dherapy in complex patients. Antimicrob Agents Chemother 2006; 50: 1599–602.

15.

15. Taylor

, Estes

, Wilson

. Linezolid and serotonergic drug interactions (letter). Clin Infect Dis 2006; 43: 1371.

16.

16. Lorenz

, Vandenberg

, Canepa

. Serotonergic antidepressants and linezolid: a retrospective chart review and presentation of cases. Int J Psychiatry Med 2008; 38: 81–90.

17.

17. Go

, Golightly

, Barber

, Barron

. Linezolid interaction with serotonin reuptake inhibitors: report of two cases and incidence assessment. Drug Metabol Drug Interact 2010; 25: 41–7.

18.

18. Lawrence

, Adra

, Gillman

. Serotonin toxicity associated with the use of linezolid: a review of postmarketing data. Clin Infect Dis 2006; 42: 1578–83.

19.

19. Morrison

, Rowe

. Probable drug-drug interaction leading to serotonin syndrome in a patient treated with concomitant buspirone and linezolid in the setting of therapeutic hypothermia. J Clin Pharm Ther 2012; 37: 610–3.

20.

20. Bernard

, Stern

, Lew

, Hoffmeyer

. Serotonin syndrome after concomitant treatment with linezolid and citalopram. Clin Infect Dis 2003; 36: 1197.

21.

21. Hachem

, Hicks

, Huen

, Raad

. Myelosuppression and serotonin syndrome associated with concurrent ese of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipientc. Clin Infect Dis 2003; 37: e8–11.

22.

2. Tahir

. Serotonin syndrome as a consequence of drug-resistant infections: an interaction between linezolid and citalopram. J Am Med Dir Assoc 2004; 5: 111–3.

23.

23. Bergeron

, Boulé

, Perreault

. Serotonin toxicity associated with concomitant use of linezolid. Ann Pharmacother 2005; 39: 956–61. DOI: 10.1345/aph.1E523

24.

24. DeBellis

, Schaefer

, Liquori

, Volturo

. Linezolid- associated serotonin syndrome after concomitant treatment with citalopram and mirtazepine in a critically ill bone marrow transplant recipient. J Intensive Care Med 2005; 20: 351–3.

25.

25. McClean

, Walsh

, Condon

. Serotonin syndrome in an orthopaedic patient secondary to linezolid therapy for MRSA infection. Ir J Med Sci 2011; 180: 285–6.

26.

26. Strouse

, Kerrihard

, Forscher

, Zakowski

. Serotonin syndrome precipitated by linezolid in a medically ill patient on duloxetine. J Clin Psychopharmacol 2006; 26: 681–3.

27.

27. Thomas

, Rosenberg

, Blythe

, Meyer

III . Serotonin syndrome and linezolid (letter). J Am Acad Child Adolesc Psychiatry 2004; 43: 790.

28.

28. Morales

, Vermette

. Serotonin syndrome associated with linezolid treatment after discontinuation of fluoxetine. Psychosomatics 2005; 46: 274–5.

29.

29. Steinberg

, Morin

. Mild serotonin syndrome associated with concurrent linezolid and fluoxetine. Am J Health Syst Pharm 2007; 64: 59–62.

30.

30. Das

, Warkentin

, Hewko

, Forrest

. Serotonin syndrome after concomitant treatment with linezolid and meperidine. Clin Infect Dis 2008; 46: 264–5.

31.

31. Aga

, Barlage

, Jefferson

. Linezolid, a monoamine oxidase inhibiting antibiotic, and antidepressants. J Clin Psychiatry 2003; 64: 609–11.

32.

32. Wigen

, Goetz

. Serotonin syndrome and linezolid. Clin Infect Dis 2002; 34: 1651–2.

33.

33. Lavery

, Ravi

, McDaniel

, Pushkin

. Linezolid and serotonin syndrome. Psychosomatics 2001; 42: 432–4.

34.

34. Clark

, Andrus

, Byrd

. Drug interactions between linezolid and selective serotonin reuptake inhibitors: case report involving sertraline and review of the literature. Pharmacotherapy 2006; 26: 269–76.

35.

35. Sahiner

, Erden

. Serotonin syndrome associated with linezolid use: a case report. Turk Psikiyatri Derg 2009; 20: 398–402.

36.

36. Jones

, Athan

, O'Brien

. Serotonin syndrome due to co-administration of linezolid and venlafaxine. J Antimicrob Chemother 2004; 54: 289–90.

37.

37. Packer

, Berman

. Serotonin syndrome precipitated by the monoamine oxidase inhibitor linezolid. Am J Psychiatry 2007; 164: 346–7.

38.

38. Mason

, Randhawa

, Carpenter

. Serotonin toxicity as a consequence of linezolid use in revision hip arthroplasty. Orthopedics 2008; 31: 1140.

39.

39. Miller

, Lovell

. Antibiotic-induced serotonin syndrome. J Emerg Med 2011; 40: 25–7.

40.

40. Marcucci

, Sandson

, Dunlap

. Linezolid-bupropion interaction as possible etiology of severe intermittent intraoperative hypertension? Anesthesiology 2004; 101: 1487–8.

41.

41. Serio

. Acute delirium associated with combined diphenhydramine and linezolid use. Ann Pharmacother 2004; 38: 62–5. DOI: 10.1345/aph.1D018

42.

42. Ferry

, Ponceau

, Simon

, Possibly linezolid-induced peripheral and central neurotoxicity: report of four cases. Infection 2005; 33: 151–4.

43.

43. Dardis

, Omoregie

, Ly

. Fatal serotonin syndrome precipitated by oxcarbazepine in a patient using a selective serotonin reuptake inhibitor. Neurologist 2012; 18: 204–5.

44.

44. Beekmann SE, Gilbert DN, Polgreen PM, IDSA Emerging Infections Network. Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey. Diagn Microbiol Infect Dis 2008; 62: 407–10.

45.

45. Ables

, Nagubilli

. Prevention, recognition, and management of serotonin syndrome. Am Fam Physician 2010; 81: 1139–42.

46.

46. Flomenbaum

, Goldfrank

, Hoffman

, Howland

, Lewin

, Nelson

. Principles of managing the poisoned or overdosed patient. In: Goldfrank's toxicologic emergencies. 8th ed. New York: McGraw-Hill Medical, 2006: 231–2.